Video Experimental Relacionado
Updated: Feb 20, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
Published on: September 26, 2025
Optimización de la farmacófora secundaria para adaptar la cariprazina a trastornos duales
Caleb D Vogt1, Julie Sanchez2, Alessandro Bonifazi3
1Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse - Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, MD, 21224, United States.
Nuevos candidatos a fármacos muestran ser prometedores para el tratamiento de enfermedades mentales comórbidas y trastornos por uso de psicoestimulantes. Estos compuestos novedosos ofrecen una selectividad mejorada del receptor de dopamina D3, lo que podría reducir los efectos secundarios en comparación con la cariprazina.
Videos de Conceptos Relacionados
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

